Faculty
Ved Gossain, M.D., Professor, Division Chief
Saleh Aldasouqi M.D., Associate Professor
G, Matthew Hebdon, M.D., Assistant Professor

Overview
In the Division of Endocrinology and Metabolism, our mission is to educate, train and inspire learners, advance knowledge, and provides high quality, compassionate, cost conscious care to patients and their families.

The Division provides teaching in the area of endocrinology and metabolism to medical students, residents, fellows, and allied health professionals.  Faculty members teach in lecture format, small group learning sessions, and in one-on-one teaching sessions.  Medical students may take Endocrinology as an elective rotation.  During this rotation, they spend four weeks with the faculty members in the inpatient and outpatient settings.  Dr. Gossain is a key leader in the second-year medical student Problem Based Learning course Metabolic, Endocrine & Reproductive Endocrinology. He also serves as a "mentor" for undergraduate minority students. Dr. Aldasouqi is an experienced endocrinologist. He was recently certified as ECNU – by AACE. He also serves as the medical director of our affiliated Sparrow Regional Diabetes Center, where medical students and residents rotate for their training in diabetes. Dr. Hebdon worked in the pharmaceutical industry before attending medical school. He is trained in both pediatric and adult endocrinology. The Division offers a two year fellowship in Endocrinology & Metabolism which is fully accredited by ACGME (Accreditation Council for Graduate Medical Education). The fellowship is sponsored by Michigan State University and is a partnership with E.W. Sparrow Hospital. Fellows receive instruction from MSU based faculty and clinical faculty in our community.

The Division conducts clinical research and participates in basic research in collaboration with basic science faculty.  An example is the Global Hypopituitary Control and Complications Study (HypoCCS) which is part of an international collaboration project to evaluate the effects of growth hormone replacement in growth hormone deficient adults.  Other studies include an evaluation of a Shared Decision Making model to improve the care of diabetes and a study to evaluate the utility of MRI in the early detection of diabetic microangiopathy.   A recently funded study investigated the prevalence of diabetes/cardiovascular risk factors and the effectiveness of risk factor modification among UAW-GM employees.  Other important projects deal with the use of glycosylated hemoglobin in gestational diabetes, the effectiveness of insulin pumps in community settings, fatty acid profiles in diabetics, and the natural history of subclinical hyperthyroidism with and without treatment.  The outcome of the studies outlined above will advance knowledge, and depending on the results, may result in improved treatment of patients affected by the endocrine disorders. 

Contact:
Academic: 517-353-3730
Clinical Center: 517-353-4830 or http://www.healthteam.msu.edu/ClinicDetails.aspx?ID=MSUENDO
Sparrow Regional Diabetes Center: 517-364-5595